[go: up one dir, main page]

CN107759574B - A kind of 5-fluoro-1H-pyrazole-3-carboxylate intermediate and its synthesis method - Google Patents

A kind of 5-fluoro-1H-pyrazole-3-carboxylate intermediate and its synthesis method Download PDF

Info

Publication number
CN107759574B
CN107759574B CN201710753540.0A CN201710753540A CN107759574B CN 107759574 B CN107759574 B CN 107759574B CN 201710753540 A CN201710753540 A CN 201710753540A CN 107759574 B CN107759574 B CN 107759574B
Authority
CN
China
Prior art keywords
compound
iii
preparation
compound iii
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201710753540.0A
Other languages
Chinese (zh)
Other versions
CN107759574A (en
Inventor
范海江
管增东
夏爱华
李辉
揭元萍
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmablock Sciences Nanjing Inc
Original Assignee
Pharmablock Sciences Nanjing Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmablock Sciences Nanjing Inc filed Critical Pharmablock Sciences Nanjing Inc
Priority to CN201710753540.0A priority Critical patent/CN107759574B/en
Publication of CN107759574A publication Critical patent/CN107759574A/en
Application granted granted Critical
Publication of CN107759574B publication Critical patent/CN107759574B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16Halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

本发明公开了一种结构式IV的化合物及其合成方法,以及化合物IV在5‑氟‑1H‑吡唑‑3‑甲酸酯(化合物I)合成上的应用,属于有机化学合成领域,该方法以N‑取代的5‑氟‑吡唑(化合物II)为原料,在催化剂作用下重排得到化合物III,再通过羧化和酯化反应就可以顺利地合成出取代的1H‑吡唑‑3‑甲酸酯。该方法操作简单,路线短,并且获得的产物收率高、适用于规模生产。The invention discloses a compound of structural formula IV and a synthesis method thereof, as well as the application of compound IV in the synthesis of 5-fluoro-1H-pyrazole-3-formate (compound I), belonging to the field of organic chemical synthesis. The method Using N-substituted 5-fluoro-pyrazole (compound II) as raw material, rearrangement under catalyst action obtains compound III, and then substituted 1H-pyrazole-3 can be smoothly synthesized through carboxylation and esterification reactions ‑ Formate. The method has the advantages of simple operation, short route and high product yield, which is suitable for large-scale production.

Description

一种5-氟-1H-吡唑-3-甲酸酯中间体及其合成方法A kind of 5-fluoro-1H-pyrazole-3-carboxylate intermediate and its synthesis method

技术领域technical field

本发明涉及有机化学合成领域,具体地说涉及合成5-氟-1H-吡唑-3-甲酸酯中间体及其合成方法。The invention relates to the field of organic chemical synthesis, in particular to the synthesis of a 5-fluoro-1H-pyrazole-3-carboxylate intermediate and a synthesis method thereof.

背景技术Background technique

卤素取代的1H-吡唑-3-甲酸酯在医药领域有着广泛的应用,例如可用于制备脂质合成的杂环调节剂化合物以及其药学上可接受的盐,合成11-β羟基类固醇脱氢酶类型1抑制剂和V1b受体拮抗体等。Halogen-substituted 1H-pyrazole-3-carboxylate has a wide range of applications in the field of medicine, such as the preparation of heterocyclic regulator compounds for lipid synthesis and pharmaceutically acceptable salts thereof, and the synthesis of 11-β hydroxy steroids. Hydrogenase type 1 inhibitors and V1b receptor antagonists, etc.

在CN 106061963 A中报道的路线如下:The route reported in CN 106061963 A is as follows:

Figure GDA0002263082890000011
Figure GDA0002263082890000011

试剂和收率:(a)MeOH,H2SO4,收率70%;(b)Pd/C,H2,MeOH,收率:73%;(c)NaNO2,KI,H2SO4,H2O,收率30%。Reagents and yields: (a) MeOH, H2SO4 , 70% yield; (b) Pd/C, H2 , MeOH, 73% yield ; (c ) NaNO2 , KI, H2SO4 , H 2 O, yield 30%.

该报道的方法存在以下不足:该合成路线总收率为15.3%,收率较低;b步骤中加氢反应有一定的危险性;c步骤中重氮化反应有火灾危险性,重氮化反应所产生的重氮盐,在温度稍高或光的作用下,即易分解,有的甚至在室温时也能分解,在干燥状态下,有些重氮盐不稳定,活力大,受热或摩擦、撞击,能分解爆炸。The reported method has the following shortcomings: the total yield of the synthetic route is 15.3%, and the yield is relatively low; the hydrogenation reaction in step b has certain danger; the diazotization reaction in step c has fire hazard, and the diazotization reaction is dangerous. The diazonium salt produced by the reaction is easy to decompose under the action of slightly higher temperature or light, and some can even decompose at room temperature. , impact, can decompose and explode.

Venkat Gaddamidi等人在J.Agric.Food Chem.,2011,59,9424–9432文献报道以3-溴吡唑为原料,先与二甲基硫酰氯反应形成N-二甲基硫酰基衍生物以保护氮,然后在-70℃下与二异丙氨基锂作用,并用二氧化碳淬灭,最后用甲醇酯化,得到3-溴-1H-吡唑-5-甲酸甲酯。Venkat Gaddamidi et al. reported in J.Agric.Food Chem., 2011, 59, 9424–9432 that 3-bromopyrazole was used as a raw material, first reacted with dimethylsulfuryl chloride to form N-dimethylsulfanyl derivatives, Protected nitrogen, then reacted with lithium diisopropylamide at -70°C, quenched with carbon dioxide, and finally esterified with methanol to give methyl 3-bromo-1H-pyrazole-5-carboxylate.

发明内容SUMMARY OF THE INVENTION

本发明的目的是提供一种新的5-氟-1H-吡唑-3-甲酸酯的中间体(化合物IV),从化合物IV一步反应得到5-氟-1H-吡唑-3-甲酸酯。同时本发明以化合物II为原料,在催化剂作用下重排得到化合物III,再通过羧化得到合成出化合物IV。The object of the present invention is to provide a new intermediate (compound IV) of 5-fluoro-1H-pyrazole-3-carboxylate, and obtain 5-fluoro-1H-pyrazole-3-carboxylate from compound IV by one-step reaction acid ester. Meanwhile, in the present invention, compound II is used as a raw material, and compound III is obtained by rearrangement under the action of a catalyst, and then compound IV is synthesized through carboxylation.

一种结构式IV的化合物:A compound of formula IV:

Figure GDA0002263082890000021
Figure GDA0002263082890000021

化合物IV的制备方法:用化合物II为原料,The preparation method of compound IV: using compound II as raw material,

Figure GDA0002263082890000022
Figure GDA0002263082890000022

(1)先在催化剂的作用下重排,得到化合物III(1) First rearrangement under the action of a catalyst to obtain compound III

Figure GDA0002263082890000023
Figure GDA0002263082890000023

(2)然后在强碱的作用下与二氧化碳或干冰进行羧化,得到化合物IV(2) then carboxylate with carbon dioxide or dry ice under the action of strong base to obtain compound IV

Figure GDA0002263082890000024
Figure GDA0002263082890000024

在步骤(1)中所述催化剂可选自:三氟乙酸、对甲苯磺酸一水合物、三氟甲磺酸、苯磺酸、甲磺酸;溶剂可选自:二甲苯、甲苯、氯苯。反应温度范围在110~140℃;反应时间在6~60小时。In step (1), the catalyst can be selected from: trifluoroacetic acid, p-toluenesulfonic acid monohydrate, trifluoromethanesulfonic acid, benzenesulfonic acid, and methanesulfonic acid; the solvent can be selected from: xylene, toluene, chlorine benzene. The reaction temperature ranges from 110 to 140°C; the reaction time ranges from 6 to 60 hours.

步骤(2)中所述强碱可选自正丁基锂、叔丁基锂、二异丙基氨基锂(LDA)、二(三甲基硅基)氨基锂(LiHMDS)、二(三甲基硅基)氨基钠(NaHMDS)、二氯化镁(2,2,6,6-四甲基哌啶)锂盐、苯基锂。化合物III与强碱的摩尔比为1.0∶1.0~1.0∶3.0。反应温度为-78~-30℃。反应溶剂选自四氢呋喃、乙醚、2-甲基四氢呋喃、环戊基甲醚。The strong base described in step (2) can be selected from n-butyllithium, tert-butyllithium, lithium diisopropylamide (LDA), lithium bis(trimethylsilyl)amide (LiHMDS), bis(trimethyl) Silyl) sodium amide (NaHMDS), magnesium dichloride (2,2,6,6-tetramethylpiperidine) lithium salt, phenyllithium. The molar ratio of compound III to strong base is 1.0:1.0~1.0:3.0. The reaction temperature is -78 to -30°C. The reaction solvent is selected from tetrahydrofuran, diethyl ether, 2-methyltetrahydrofuran, and cyclopentyl methyl ether.

由化合物IV制备化合物I的方法,化合物IVProcess for preparing compound I from compound IV, compound IV

Figure GDA0002263082890000031
Figure GDA0002263082890000031

在氯化亚砜的作用下,与ROH发生酯化反应得到化合物IUnder the action of thionyl chloride, compound I is obtained by esterification with ROH

Figure GDA0002263082890000032
Figure GDA0002263082890000032

其中R为甲基或乙基。化合物IV与氯化亚砜的摩尔比为1.0∶1.5~1.0∶3.5。wherein R is methyl or ethyl. The molar ratio of compound IV to thionyl chloride is 1.0:1.5-1.0:3.5.

由化合物II制备化合物I的方法:用化合物II为原料,The method for preparing compound I from compound II: using compound II as starting material,

Figure GDA0002263082890000033
Figure GDA0002263082890000033

(1)先在催化剂的作用下重排,得到化合物III(1) First rearrangement under the action of a catalyst to obtain compound III

Figure GDA0002263082890000034
Figure GDA0002263082890000034

(2)然后在强碱的作用下与二氧化碳或干冰进行羧化,得到化合物IV(2) then carboxylate with carbon dioxide or dry ice under the action of strong base to obtain compound IV

Figure GDA0002263082890000041
Figure GDA0002263082890000041

(3)在氯化亚砜的作用下,与ROH发生酯化反应得到化合物I(3) under the action of thionyl chloride, esterification with ROH to obtain compound I

Figure GDA0002263082890000042
Figure GDA0002263082890000042

其中R为甲基或乙基。化合物IV与氯化亚砜的摩尔比为1.0∶1.5~1.0∶3.5。wherein R is methyl or ethyl. The molar ratio of compound IV to thionyl chloride is 1.0:1.5-1.0:3.5.

有益效果:Beneficial effects:

尽管现有技术对卤素取代的1H-吡唑-3-甲酸酯已有一定程度的研究,但氟代的1H-吡唑-3-甲酸酯在本领域中仍未见报道。在医药方面,含氟芳香族化合物为活性基团的一类药物有着举足轻重的作用。当氟原子或含氟基团引入化合物中,其电效应和模拟效应改变了分子内部电子密度的分布,影响了化合物内部结构的酸碱性,进而改变了其活性,而且还能提高化合物的脂溶性。氟原子取代了化合物中的氢原子,其酯类化合物在生物膜上的溶解性得到了增强,促进其在生物体内吸收的传递速度,使生理作用发生变化。所以不少含氟化合物比不含氟化合物在医药、农药等药物性能上具有用量少、毒性低、药效高、代谢能力强的优点。Although halogen-substituted 1H-pyrazole-3-carboxylates have been studied to some extent in the prior art, fluorinated 1H-pyrazole-3-carboxylates have not been reported in the art. In medicine, a class of medicines with fluorine-containing aromatic compounds as active groups plays a pivotal role. When a fluorine atom or a fluorine-containing group is introduced into a compound, its electrical effect and analog effect change the distribution of electron density inside the molecule, affect the acidity and alkalinity of the internal structure of the compound, and then change its activity, and can also improve the lipid of the compound. soluble. The fluorine atom replaces the hydrogen atom in the compound, and the solubility of the ester compound in the biofilm is enhanced, which promotes the transfer speed of its absorption in the living body, and changes the physiological effect. Therefore, many fluorine-containing compounds have the advantages of less dosage, lower toxicity, higher efficacy and stronger metabolism than non-fluorine-containing compounds in terms of pharmaceutical properties such as medicines and pesticides.

本发明提供一种新的5-氟-1H-吡唑-3-甲酸酯的中间体(化合物IV),从化合物IV一步反应得到5-氟-1H-吡唑-3-甲酸酯。同时本发明以化合物II为原料,在催化剂作用下重排得到化合物III,再通过羧化得到合成出化合物IV。该路线牵涉到的步骤短,操作简单,工艺重复性好,易于纯化,总收率高达61.1%,易于批量生产。The present invention provides a novel intermediate of 5-fluoro-1H-pyrazole-3-carboxylate (compound IV), and 5-fluoro-1H-pyrazole-3-carboxylate can be obtained by one-step reaction of compound IV. Meanwhile, in the present invention, compound II is used as a raw material, and compound III is obtained by rearrangement under the action of a catalyst, and then compound IV is synthesized through carboxylation. The steps involved in this route are short, the operation is simple, the process repeatability is good, the purification is easy, the total yield is as high as 61.1%, and the batch production is easy.

说明书中涉及到的反应试剂的缩写如下所示:The abbreviations of the reagents involved in the specification are as follows:

LiHMDS 二(三甲基硅基)氨基锂;LiHMDS lithium bis(trimethylsilyl)amide;

LDA 二异丙基氨基锂;LDA lithium diisopropylamide;

NaHMDS 二(三甲基硅基)氨基钠;NaHMDS sodium bis(trimethylsilyl)amide;

LTMPMgCl2 二氯化镁(2,2,6,6-四甲基哌啶)锂盐;LTMPMgCl 2 magnesium dichloride (2,2,6,6-tetramethylpiperidine) lithium salt;

THF 四氢呋喃;THF tetrahydrofuran;

TsOH·H2O 对甲基苯磺酸一水合物。TsOH·H 2 O p-toluenesulfonic acid monohydrate.

具体实施方式Detailed ways

本发明用下列实施例来进一步说明本发明,但本发明的保护范围并不限于实施例。本领域的技术人员在不背离本发明的精神和保护范围的情况下可做出许多其它的变化和修改,这些变化和修改仍包括在权利要求书中保护的范围内。The present invention uses the following examples to further illustrate the present invention, but the protection scope of the present invention is not limited to the examples. Those skilled in the art can make many other changes and modifications without departing from the spirit and protection scope of the present invention, and these changes and modifications are still included in the protection scope of the claims.

实施例1Example 1

Figure GDA0002263082890000051
Figure GDA0002263082890000051

化合物II制备化合物III:Compound II prepares compound III:

将化合物II(120.0g,0.705mol,1.0e.q.)加入二甲苯(1200mL),再加入三氟乙酸(4.02g,0.0353mol,0.05e.q.),加完后升温至140℃,反应6小时,GC检测原料反应完,加入饱和碳酸钠水溶液洗涤,用乙酸乙酯萃取(3×900mL),用无水硫酸镁干燥,过滤,滤液浓缩干得化合物III黄色液体108.0g,收率90.0%。Compound II (120.0g, 0.705mol, 1.0e.q.) was added to xylene (1200mL), and then trifluoroacetic acid (4.02g, 0.0353mol, 0.05e.q.) was added, and the temperature was raised to 140°C after the addition, reacted for 6 hours, and detected by GC The raw materials were reacted, washed with saturated aqueous sodium carbonate solution, extracted with ethyl acetate (3×900 mL), dried over anhydrous magnesium sulfate, filtered, and the filtrate was concentrated to dryness to obtain compound III yellow liquid 108.0 g, yield 90.0%.

化合物III制备化合物IV:Compound III prepares compound IV:

将化合物III(70.0g,0.411mol,1.0e.q.)溶解在THF(700mL)中,氮气保护下,-78℃滴加2.5M正丁基锂/正已烷(197mL,0.494mol,1.2e.q.),滴毕-78℃保温20分钟,缓慢通入干燥的二氧化碳气体约15分钟后,停止通入二氧化碳,开始滴加1N的盐酸水溶液,调节pH=2,加入1L的乙酸乙酯萃取,干燥浓缩得黄色油状物,加入500mL的石油醚打浆,析出固体,过滤,得到化合物IV白色固体70.5g,收率80.0%。Compound III (70.0g, 0.411mol, 1.0e.q.) was dissolved in THF (700mL), under nitrogen protection, 2.5M n-butyllithium/n-hexane (197mL, 0.494mol, 1.2e.q.) was added dropwise at -78°C, After dripping at -78°C for 20 minutes, slowly introducing dry carbon dioxide gas for about 15 minutes, stopping the introduction of carbon dioxide, starting to drip 1N aqueous hydrochloric acid solution, adjusting pH=2, adding 1L ethyl acetate for extraction, drying and concentrating to obtain The yellow oil was added with 500 mL of petroleum ether to make a slurry, and the solid was precipitated and filtered to obtain 70.5 g of compound IV as a white solid with a yield of 80.0%.

化合物IV制备化合物I-1:Compound IV prepares compound I-1:

将化合物IV(70.0g,0.327mol,1.0e.q.)溶于甲醇(500mL)中,冰水浴条件下,滴加氯化亚砜(77.8g,0.654mol,2.0e.q.),滴毕回流10h,浓缩反应液,用饱和碳酸氢钠调节pH=8,再用乙酸乙酯(500mL×2)萃取,干燥浓缩,浓缩液用乙酸乙酯与石油醚(体积:体积=1:50)打浆,得化合物I-1白色固体36.9g,收率78.2%。Compound IV (70.0 g, 0.327 mol, 1.0 e.q.) was dissolved in methanol (500 mL), and thionyl chloride (77.8 g, 0.654 mol, 2.0 e.q.) was added dropwise under ice-water bath conditions, refluxed for 10 h after dripping, and the reaction was concentrated. The solution was adjusted to pH=8 with saturated sodium bicarbonate, extracted with ethyl acetate (500 mL×2), dried and concentrated, and the concentrate was slurried with ethyl acetate and petroleum ether (v:v=1:50) to obtain compound I -1 White solid 36.9 g, yield 78.2%.

实施例2Example 2

Figure GDA0002263082890000061
Figure GDA0002263082890000061

化合物II制备化合物III:Compound II prepares compound III:

将化合物II(125.4g,0.737mol,1.0e.q.)加入甲苯(1200mL),再加入对甲基苯磺酸一水合物(7.00g,0.0369mol,0.05e.q.),加完后升温至110℃,反应60小时,GC检测原料反应完,加入饱和碳酸钠水溶液洗涤,用乙酸乙酯萃取(3×900mL),用无水硫酸镁干燥,过滤,滤液浓缩干得化合物III黄色液体117.0g,收率93.3%。Compound II (125.4g, 0.737mol, 1.0e.q.) was added to toluene (1200mL), and then p-toluenesulfonic acid monohydrate (7.00g, 0.0369mol, 0.05e.q.) was added, and the temperature was raised to 110°C after the addition was completed. After 60 hours, the reaction of the raw materials was detected by GC, washed with saturated aqueous sodium carbonate solution, extracted with ethyl acetate (3×900 mL), dried with anhydrous magnesium sulfate, filtered, and the filtrate was concentrated to give compound III yellow liquid 117.0 g, yield 93.3 %.

化合物III制备化合物IV:Compound III prepares compound IV:

将化合物III(75.1g,0.441mol,1.0e.q.)溶解在乙醚(650mL)中,氮气保护下,-78℃滴加1.3M叔丁基锂/庚烷(407mL,0.529mol,1.2e.q.),滴毕-78℃保温35分钟,缓慢通入干燥的二氧化碳气体约20分钟后,停止通入二氧化碳,开始滴加1N的氯化氢水溶液,调节pH=2,加入1L的乙酸乙酯萃取,干燥浓缩得黄色油状物,加入500mL的石油醚打浆,析出固体,过滤,得到化合物IV白色固体77.4g,收率81.9%。Compound III (75.1g, 0.441mol, 1.0e.q.) was dissolved in ether (650mL), under nitrogen protection, 1.3M tert-butyllithium/heptane (407mL, 0.529mol, 1.2e.q.) was added dropwise at -78°C, dropwise After finishing the temperature at -78°C for 35 minutes, slowly introducing dry carbon dioxide gas for about 20 minutes, stopping the introduction of carbon dioxide, starting to drip 1N aqueous hydrogen chloride solution, adjusting pH=2, adding 1L ethyl acetate for extraction, drying and concentrating to obtain yellow The oily substance was added with 500 mL of petroleum ether to make a slurry, and the solid was precipitated and filtered to obtain 77.4 g of compound IV as a white solid with a yield of 81.9%.

化合物IV制备化合物I-1:Compound IV prepares compound I-1:

将化合物IV(70.0g,0.327mol,1.0e.q.)溶于甲醇(500mL)中,冰水浴条件下,滴加氯化亚砜(58.4g,0.491mol,1.5e.q.),滴毕回流10h,浓缩反应液,用饱和碳酸氢钠调节pH=8,再用乙酸乙酯(500mL×2)萃取,干燥浓缩,浓缩液用乙酸乙酯与石油醚(体积:体积=1:50)打浆,得化合物I-1白色固体37.7g,收率80.1%。Compound IV (70.0g, 0.327mol, 1.0e.q.) was dissolved in methanol (500mL), under ice-water bath conditions, thionyl chloride (58.4g, 0.491mol, 1.5e.q.) was added dropwise, refluxed for 10h after dripping, and the reaction was concentrated The solution was adjusted to pH=8 with saturated sodium bicarbonate, extracted with ethyl acetate (500 mL×2), dried and concentrated, and the concentrate was slurried with ethyl acetate and petroleum ether (v:v=1:50) to obtain compound I -1 White solid 37.7 g, yield 80.1%.

实施例3Example 3

Figure GDA0002263082890000071
Figure GDA0002263082890000071

化合物II制备化合物III:Compound II prepares compound III:

将化合物II(122.6g,0.720mol,1.0e.q.)加入氯苯(1200mL),再加入苯磺酸(5.69g,0.0360mol,0.05e.q.),加完后升温至130℃,反应20小时,GC检测原料反应完,加入饱和碳酸钠水溶液洗涤,用乙酸乙酯萃取(3×900mL),用无水硫酸镁干燥,过滤,滤液浓缩干得化合物III黄色液体112.5g,收率91.8%。Compound II (122.6g, 0.720mol, 1.0e.q.) was added to chlorobenzene (1200mL), then benzenesulfonic acid (5.69g, 0.0360mol, 0.05e.q.) was added, the temperature was raised to 130°C after the addition, and the reaction was performed for 20 hours. After the raw materials were reacted, a saturated aqueous sodium carbonate solution was added to wash, extracted with ethyl acetate (3×900 mL), dried over anhydrous magnesium sulfate, filtered, and the filtrate was concentrated to dryness to obtain 112.5 g of compound III as a yellow liquid with a yield of 91.8%.

化合物III制备化合物IV:Compound III prepares compound IV:

将化合物III(80.3g,0.472mol,1.0e.q.)溶解在2-甲基四氢呋喃(800mL)中,氮气保护下,-60℃滴加2.0M LDA/正已烷(283mL,0.566mol,1.2e.q.),滴毕-60℃保温60分钟,缓慢通入干燥的二氧化碳气体约30分钟后,停止通入二氧化碳,开始滴加1N的氯化氢水溶液,调节pH=2,加入1L的乙酸乙酯萃取,干燥浓缩得黄色油状物,加入500mL的石油醚打浆,析出固体,过滤,得到化合物IV白色固体81.2g,收率80.3%。Compound III (80.3g, 0.472mol, 1.0e.q.) was dissolved in 2-methyltetrahydrofuran (800mL), under nitrogen protection, 2.0M LDA/n-hexane (283mL, 0.566mol, 1.2e.q.) was added dropwise at -60°C , keep the temperature at -60°C for 60 minutes after dripping, slowly introduce dry carbon dioxide gas for about 30 minutes, stop the introduction of carbon dioxide, start to drip 1N aqueous hydrogen chloride solution, adjust pH=2, add 1L of ethyl acetate for extraction, dry and concentrate A yellow oil was obtained, and 500 mL of petroleum ether was added to make a slurry, and a solid was precipitated, which was filtered to obtain 81.2 g of compound IV as a white solid with a yield of 80.3%.

化合物IV制备化合物I-1:Compound IV prepares compound I-1:

将化合物IV(70.0g,0.327mol,1.0e.q.)溶于甲醇(500mL)中,冰水浴条件下,滴加氯化亚砜(97.3g,0.818mol,2.5e.q.),滴毕回流10h,浓缩反应液,用饱和碳酸氢钠调节pH=8,再用乙酸乙酯(500mL×2)萃取,干燥浓缩,浓缩液用乙酸乙酯与石油醚(体积:体积=1:50)打浆,得化合物I-1白色固体37.5g,收率79.5%。Compound IV (70.0 g, 0.327 mol, 1.0 e.q.) was dissolved in methanol (500 mL), thionyl chloride (97.3 g, 0.818 mol, 2.5 e.q.) was added dropwise under ice-water bath conditions, refluxed for 10 h after dripping, and the reaction was concentrated. The solution was adjusted to pH=8 with saturated sodium bicarbonate, extracted with ethyl acetate (500 mL×2), dried and concentrated, and the concentrate was slurried with ethyl acetate and petroleum ether (v:v=1:50) to obtain compound I -1 White solid 37.5g, yield 79.5%.

实施例4Example 4

Figure GDA0002263082890000072
Figure GDA0002263082890000072

化合物II制备化合物III:Compound II prepares compound III:

将化合物II(123.3g,0.724mol,1.0e.q.)加入氯苯(1200mL),再加入甲磺酸(3.48g,0.0362mol,0.05e.q.),加完后升温至120℃,反应40小时,GC检测原料反应完了,加入饱和碳酸钠水溶液洗涤,用乙酸乙酯萃取(3×900mL),用无水硫酸镁干燥,过滤,滤液浓缩干得化合物III黄色液体111.9g,收率90.8%。Compound II (123.3g, 0.724mol, 1.0e.q.) was added to chlorobenzene (1200mL), then methanesulfonic acid (3.48g, 0.0362mol, 0.05e.q.) was added, and the temperature was raised to 120°C after the addition, reacted for 40 hours, and detected by GC After the reaction of the raw materials was completed, a saturated aqueous sodium carbonate solution was added to wash, extracted with ethyl acetate (3×900 mL), dried over anhydrous magnesium sulfate, filtered, and the filtrate was concentrated to dryness to obtain 111.9 g of compound III as a yellow liquid with a yield of 90.8%.

化合物III制备化合物IV:Compound III prepares compound IV:

将化合物III(81.6g,0.479mol,1.0e.q.)溶解在环戊基甲醚(550mL)中,氮气保护下,-60℃滴加1.5M苯基锂/四氢呋喃(383mL,0.575mol,1.2e.q.),滴毕-60℃保温45分钟,缓慢通入干燥的二氧化碳气体约25分钟后,停止通入二氧化碳,开始滴加1N的氯化氢水溶液,调节pH=2,加入1L的乙酸乙酯萃取,干燥浓缩得黄色油状物,加入500mL的石油醚打浆,析出固体,过滤,得到化合物IV白色固体82.2g,收率80.1%。Compound III (81.6g, 0.479mol, 1.0e.q.) was dissolved in cyclopentyl methyl ether (550mL), and 1.5M phenyllithium/tetrahydrofuran (383mL, 0.575mol, 1.2e.q.) was added dropwise at -60°C under nitrogen protection. After dripping, the temperature was kept at -60 °C for 45 minutes, and after about 25 minutes of dry carbon dioxide gas was slowly introduced, the introduction of carbon dioxide was stopped, and 1N aqueous hydrogen chloride solution was added dropwise. A yellow oil was obtained, and 500 mL of petroleum ether was added to make a slurry, and a solid was precipitated, which was filtered to obtain 82.2 g of compound IV as a white solid with a yield of 80.1%.

化合物IV制备化合物I-1:Compound IV prepares compound I-1:

将化合物IV(70.0g,0.327mol,1.0e.q.)溶于甲醇(500mL)中,冰水浴条件下,滴加氯化亚砜(136.2g,1.15mol,3.5e.q.),滴毕回流10h,浓缩反应液,用饱和碳酸氢钠调节pH=8,再用乙酸乙酯(500mL×2)萃取,干燥浓缩,浓缩液用乙酸乙酯与石油醚(体积:体积=1:50)打浆,得化合物I-1白色固体37.2g,收率79.0%。Compound IV (70.0 g, 0.327 mol, 1.0 e.q.) was dissolved in methanol (500 mL), thionyl chloride (136.2 g, 1.15 mol, 3.5 e.q.) was added dropwise under ice-water bath conditions, refluxed for 10 h after dripping, and the reaction was concentrated. The solution was adjusted to pH=8 with saturated sodium bicarbonate, extracted with ethyl acetate (500 mL×2), dried and concentrated, and the concentrate was slurried with ethyl acetate and petroleum ether (v:v=1:50) to obtain compound I -1 White solid 37.2 g, yield 79.0%.

实施例5Example 5

Figure GDA0002263082890000081
Figure GDA0002263082890000081

化合物II制备化合物III:Compound II prepares compound III:

将化合物II(122.1g,0.717mol,1.0e.q.)加入甲苯(1200mL),再加入三氟甲磺酸(5.38g,0.0359mol,0.05e.q.),加完后升温至110℃,反应60小时,GC检测原料反应完了,加入饱和碳酸钠水溶液洗涤,用乙酸乙酯萃取(3×900mL),用无水硫酸镁干燥,过滤,滤液浓缩干得化合物III黄色液体111.5g,收率91.3%。Compound II (122.1g, 0.717mol, 1.0e.q.) was added to toluene (1200mL), then trifluoromethanesulfonic acid (5.38g, 0.0359mol, 0.05e.q.) was added, and the temperature was raised to 110°C after the addition, and the reaction was performed for 60 hours, GC After the reaction of the raw materials was detected, saturated aqueous sodium carbonate solution was added for washing, extracted with ethyl acetate (3×900 mL), dried over anhydrous magnesium sulfate, filtered, and the filtrate was concentrated to dryness to obtain 111.5 g of compound III as a yellow liquid with a yield of 91.3%.

化合物III制备化合物IV:Compound III prepares compound IV:

将化合物III(76.9g,0.452mol,1.0e.q.)溶解在四氢呋喃(600mL)中,氮气保护下,-65℃滴加2.0M LDA/正已烷(271mL,0.542mol,1.2e.q.),滴毕-65℃保温45分钟,30分钟内分批加入干冰,然后开始滴加1N的氯化氢水溶液,调节pH=2,加入1L的乙酸乙酯萃取,干燥浓缩得黄色油状物,加入500mL的石油醚打浆,析出固体,过滤,得到化合物IV白色固体78.8g,收率81.4%。Compound III (76.9g, 0.452mol, 1.0e.q.) was dissolved in tetrahydrofuran (600mL), and under nitrogen protection, 2.0M LDA/n-hexane (271mL, 0.542mol, 1.2e.q.) was added dropwise at -65°C, and the dropwise completed- Incubate at 65°C for 45 minutes, add dry ice in batches within 30 minutes, then start to drip 1N aqueous hydrogen chloride solution, adjust pH=2, add 1L of ethyl acetate for extraction, dry and concentrate to obtain a yellow oil, add 500mL of petroleum ether to beat, The solid was precipitated and filtered to obtain 78.8 g of compound IV as a white solid with a yield of 81.4%.

化合物IV制备化合物I-1:Compound IV prepares compound I-1:

将化合物IV(70.0g,0.327mol,1.0e.q.)溶于甲醇(500mL)中,冰水浴条件下,滴加氯化亚砜(58.4g,0.491mol,1.5e.q.),滴毕回流10h,浓缩反应液,用饱和碳酸氢钠调节pH=8,再用乙酸乙酯(500mL×2)萃取,干燥浓缩,浓缩液用乙酸乙酯与石油醚(体积:体积=1:50)打浆,得化合物I-1白色固体38.4g,收率81.5%。Compound IV (70.0g, 0.327mol, 1.0e.q.) was dissolved in methanol (500mL), under ice-water bath conditions, thionyl chloride (58.4g, 0.491mol, 1.5e.q.) was added dropwise, refluxed for 10h after dripping, and the reaction was concentrated The solution was adjusted to pH=8 with saturated sodium bicarbonate, extracted with ethyl acetate (500 mL×2), dried and concentrated, and the concentrate was slurried with ethyl acetate and petroleum ether (v:v=1:50) to obtain compound I -1 White solid 38.4g, yield 81.5%.

实施例6Example 6

Figure GDA0002263082890000091
Figure GDA0002263082890000091

化合物II制备化合物III:Compound II prepares compound III:

用实施例1中同样的方法制备,最后得化合物III黄色液体112.2g,收率92.1%。It was prepared by the same method as in Example 1, and finally 112.2 g of compound III was obtained as a yellow liquid with a yield of 92.1%.

化合物III制备化合物IV:Compound III prepares compound IV:

将III(82.0g,0.482mol,1.0e.q.)溶解在THF(550mL)中,氮气保护下,-65℃滴加1.0M LiHMDS/四氢呋喃(578mL,0.578mol,1.2e.q.),滴毕-65℃保温20分钟,缓慢通入干燥的二氧化碳气体约25分钟后,停止通入二氧化碳,开始滴加1N的盐酸水溶液,调节pH=2,加入1L的乙酸乙酯萃取,干燥浓缩得黄色油状物,加入500mL的石油醚打浆,析出固体,过滤,得到化合物IV白色固体83.9g,收率81.3%。III (82.0g, 0.482mol, 1.0e.q.) was dissolved in THF (550mL), under nitrogen protection, 1.0M LiHMDS/tetrahydrofuran (578mL, 0.578mol, 1.2e.q.) was added dropwise at -65°C, and the temperature was kept at -65°C. After 20 minutes, dry carbon dioxide gas was slowly introduced for about 25 minutes, the introduction of carbon dioxide was stopped, 1N aqueous hydrochloric acid solution was added dropwise, pH=2, 1L of ethyl acetate was added for extraction, dried and concentrated to obtain a yellow oil, and 500mL was added. 83.9 g of compound IV white solid was obtained by slurring the obtained petroleum ether, the solid was precipitated, and the yield was 81.3%.

化合物IV制备化合物I-2:Compound IV prepares compound 1-2:

用实施例1中同样的方法制备,仅有的变化是用500mL乙醇代替甲醇作为溶剂参与反应,得化合物I-2白色固体42.2g,收率81.6%。It was prepared by the same method as in Example 1, except that 500 mL of ethanol was used instead of methanol as a solvent to participate in the reaction to obtain 42.2 g of compound I-2 as a white solid with a yield of 81.6%.

实施例7Example 7

Figure GDA0002263082890000101
Figure GDA0002263082890000101

化合物II制备化合物III:Compound II prepares compound III:

用实施例2中同样的方法制备,最后得化合物III黄色液体117.0g,收率92.5%。It was prepared by the same method as in Example 2, and finally 117.0 g of compound III was obtained as a yellow liquid with a yield of 92.5%.

化合物III制备化合物IV:Compound III prepares compound IV:

将III(77.3g,0.454mol,1.0e.q.)溶解在乙醚(600mL)中,氮气保护下,-30℃滴加1.0M二氯化镁(2,2,6,6-四甲基哌啶)锂盐/THF(545mL,0.545mol,1.0e.q.),滴毕,-60℃保温20分钟,缓慢通入干燥的二氧化碳气体约30分钟后,停止通入二氧化碳,开始滴加1N的氯化氢水溶液,调节pH=2,加入1L的乙酸乙酯萃取,干燥浓缩得黄色油状物,加入500mL的石油醚打浆,析出固体,过滤,得到化合物IV白色固体76.4g,收率80.8%。III (77.3g, 0.454mol, 1.0e.q.) was dissolved in ether (600mL), under nitrogen protection, 1.0M magnesium dichloride (2,2,6,6-tetramethylpiperidine) lithium salt was added dropwise at -30°C /THF (545mL, 0.545mol, 1.0e.q.), after dripping, keep at -60°C for 20 minutes, slowly introduce dry carbon dioxide gas for about 30 minutes, stop the introduction of carbon dioxide, start to drip 1N aqueous hydrogen chloride solution, adjust pH= 2. Add 1 L of ethyl acetate for extraction, dry and concentrate to obtain a yellow oil, add 500 mL of petroleum ether to make a slurry, precipitate a solid, and filter to obtain 76.4 g of compound IV as a white solid with a yield of 80.8%.

化合物IV制备化合物I-1:Compound IV prepares compound I-1:

用实施例2中同样的方法制备,仅有的变化是用500mL乙醇代替甲醇作为溶剂参与反应,得化合物I-2白色固体41.8g,收率80.9%。It was prepared by the same method as in Example 2, except that 500 mL of ethanol was used instead of methanol as a solvent to participate in the reaction to obtain 41.8 g of compound I-2 as a white solid with a yield of 80.9%.

实施例8Example 8

Figure GDA0002263082890000102
Figure GDA0002263082890000102

化合物II制备化合物III:Compound II prepares compound III:

用实施例3中同样的方法制备,仅有的改变是用二甲苯代替甲苯作为溶剂,最后得化合物III黄色液体115.3g,收率90.9%。It was prepared by the same method as in Example 3, except that xylene was used instead of toluene as the solvent, and finally 115.3 g of compound III was obtained as a yellow liquid with a yield of 90.9%.

化合物III制备化合物IV:Compound III prepares compound IV:

将III(82.1g,0.482mol,1.0e.q.)溶解在2-甲基四氢呋喃(550mL)中,氮气保护下,-60℃滴加1.2M LDA/THF(482mL,0.578mol,1.2e.q.),滴毕-60℃保温35分钟,缓慢通入干燥的二氧化碳气体约35分钟后,停止通入二氧化碳,开始滴加1N的氯化氢水溶液,调节pH=2,加入1L的乙酸乙酯萃取,干燥浓缩得黄色油状物,加入500mL的石油醚打浆,析出固体,过滤,得到化合物IV白色固体83.9g,收率81.3%。III (82.1g, 0.482mol, 1.0e.q.) was dissolved in 2-methyltetrahydrofuran (550mL), under nitrogen protection, 1.2M LDA/THF (482mL, 0.578mol, 1.2e.q.) was added dropwise at -60°C, and the drop was completed. -60°C for 35 minutes, slowly feed dry carbon dioxide gas for about 35 minutes, stop feeding carbon dioxide, start dropwise addition of 1N aqueous hydrogen chloride solution, adjust pH=2, add 1L of ethyl acetate for extraction, dry and concentrate to obtain a yellow oil 500 mL of petroleum ether was added to make slurry, and the solid was precipitated and filtered to obtain 83.9 g of compound IV as a white solid with a yield of 81.3%.

化合物IV制备化合物I-1:Compound IV prepares compound I-1:

用实施例3中同样的方法制备,仅有的变化是用500mL乙醇代替甲醇作为溶剂参与反应,得化合物I-2白色固体42.4g,收率82.0%。It was prepared by the same method as in Example 3, except that 500 mL of ethanol was used instead of methanol as a solvent to participate in the reaction to obtain 42.4 g of compound I-2 as a white solid with a yield of 82.0%.

实施例9Example 9

Figure GDA0002263082890000111
Figure GDA0002263082890000111

化合物II制备化合物III:Compound II prepares compound III:

用实施例1中同样的方法制备,最后得化合物III黄色液体114.1g,收率91.3%。It was prepared by the same method as in Example 1, and finally 114.1 g of compound III was obtained as a yellow liquid with a yield of 91.3%.

化合物III制备化合物IV:Compound III prepares compound IV:

将III(83.1g,0.488mol,1.0e.q.)溶解在环戊基甲醚(800mL)中,氮气保护下,-78℃滴加2.5M正丁基锂/正己烷(234mL,0.586mol,1.2e.q.),滴毕-60℃保温30分钟,20分钟内分批加入干冰,然后开始滴加1N的氯化氢水溶液,调节pH=2,加入1L的乙酸乙酯萃取,干燥浓缩得黄色油状物,加入500mL的石油醚打浆,析出固体,过滤,得到化合物IV白色固体81.2g,收率81.1%。III (83.1g, 0.488mol, 1.0e.q.) was dissolved in cyclopentyl methyl ether (800mL), under nitrogen protection, 2.5M n-butyllithium/n-hexane (234mL, 0.586mol, 1.2e.q.) was added dropwise at -78°C. ), keep the temperature at -60°C for 30 minutes after dripping, add dry ice in batches within 20 minutes, then start to drip 1N aqueous hydrogen chloride solution, adjust pH=2, add 1L ethyl acetate for extraction, dry and concentrate to obtain a yellow oil, add 500mL 81.2 g of compound IV white solid was obtained by slurring the obtained petroleum ether, the solid was precipitated, and the yield was 81.1%.

化合物IV制备化合物I-2:Compound IV prepares compound 1-2:

用实施例4中同样的方法制备,仅有的变化是用500mL乙醇代替甲醇作为溶剂参与反应,得化合物I-2白色固体41.2g,收率79.8%。It was prepared by the same method as in Example 4, except that 500 mL of ethanol was used instead of methanol as the solvent to participate in the reaction to obtain 41.2 g of compound I-2 as a white solid with a yield of 79.8%.

实施例10Example 10

Figure GDA0002263082890000121
Figure GDA0002263082890000121

化合物II制备化合物III:Compound II prepares compound III:

用实施例1中同样的方法制备,仅有的变化是用三氟甲磺酸替代三氟乙酸,最后得化合物III黄色液体113.6g,收率90.8%。It was prepared by the same method as in Example 1, except that trifluoromethanesulfonic acid was used instead of trifluoroacetic acid, and finally 113.6 g of compound III was obtained as a yellow liquid with a yield of 90.8%.

化合物III制备化合物IV:Compound III prepares compound IV:

将化合物III(75.3g,0.442mol,1.0e.q.)溶解在2-甲基四氢呋喃(600mL)中,氮气保护下,-65℃1.0M LiHMDS/四氢呋喃(530mL,0.530mol,1.2e.q.),滴毕-65℃保温45分钟,缓慢通入干燥的二氧化碳气体约35分钟后,停止通入二氧化碳,开始滴加1N的氯化氢水溶液,调节pH=2,加入1L的乙酸乙酯萃取,干燥浓缩得黄色油状物,加入500mL的石油醚打浆,析出固体,过滤,得到化合物IV白色固体76.1g,收率80.4%。Compound III (75.3g, 0.442mol, 1.0e.q.) was dissolved in 2-methyltetrahydrofuran (600mL), under nitrogen protection, -65°C 1.0M LiHMDS/tetrahydrofuran (530mL, 0.530mol, 1.2e.q.), dropwise - Incubate at 65°C for 45 minutes, slowly feed dry carbon dioxide gas for about 35 minutes, stop feeding carbon dioxide, start dropwise addition of 1N aqueous hydrogen chloride solution, adjust pH=2, add 1L of ethyl acetate for extraction, dry and concentrate to obtain a yellow oil , 500 mL of petroleum ether was added to make slurry, the solid was precipitated, and filtered to obtain 76.1 g of compound IV as a white solid with a yield of 80.4%.

化合物IV制备化合物I-2:Compound IV prepares compound 1-2:

用实施例6中同样的方法制备,得化合物I-2白色固体42.4g,收率82.1%。It was prepared by the same method as in Example 6 to obtain 42.4 g of compound I-2 as a white solid with a yield of 82.1%.

表一、化合物结构解析Table 1. Compound structure analysis

Figure GDA0002263082890000131
Figure GDA0002263082890000131

Claims (9)

1. A process for the preparation of compound IV, which comprises:
starting from compounds II
Figure FDA0002491634460000011
(1) Firstly, rearrangement is carried out under the action of a catalyst to obtain a compound III
Figure FDA0002491634460000012
(2) Then carboxylating with carbon dioxide or dry ice under the action of strong alkali to obtain a compound IV
Figure FDA0002491634460000013
In the preparation of compound II compound III step (1) the catalyst is selected from: trifluoroacetic acid, p-toluenesulfonic acid monohydrate, trifluoromethanesulfonic acid, benzenesulfonic acid, methanesulfonic acid.
2. The process for the preparation of compound IV according to claim 1, compound III in step (1) of compound II
The medium solvent is selected from: xylene, toluene, chlorobenzene.
3. The method for preparing the compound IV according to claim 1, wherein the reaction temperature in the step (1) of preparing the compound III from the compound II is in the range of 110-140 ℃; the reaction time is 6-60 hours.
4. The process for the preparation of compound IV according to claim 1, wherein in the step (2) of the preparation of compound IV from compound III, the strong base is selected from the group consisting of n-butyllithium, t-butyllithium, lithium diisopropylamide, lithium bis (trimethylsilyl) amide, sodium bis (trimethylsilyl) amide, lithium magnesium dichloride (2,2,6, 6-tetramethylpiperidine), and phenyllithium.
5. The process for producing compound IV according to claim 1 or claim 4, wherein the molar ratio of compound III to the strong base in the step (2) of producing compound IV from compound III is 1.0: 1.0 to 1.0: 3.0.
6. The process for the preparation of compound IV according to claim 1 or claim 4, wherein the reaction temperature in the step (2) of preparing compound IV from compound III is-78 to-30 ℃.
7. The process for the preparation of compound IV according to claim 1 or claim 4, wherein the reaction solvent in step (2) of the preparation of compound IV from compound III is selected from the group consisting of tetrahydrofuran, diethyl ether, 2-methyltetrahydrofuran, and cyclopentylmethyl ether.
8. A process for the preparation of a compound of formula I, characterized in that a compound IV
Figure FDA0002491634460000021
Under the action of thionyl chloride, the compound and ROH are subjected to esterification reaction to obtain a compound I
Figure FDA0002491634460000022
Wherein R is methyl or ethyl;
further comprising the step of preparing compound IV according to claim 1.
9. The method for preparing the compound of formula I according to claim 8, wherein the molar ratio of the compound IV to the thionyl chloride is 1.0: 1.5-1.0: 3.5.
CN201710753540.0A 2017-08-29 2017-08-29 A kind of 5-fluoro-1H-pyrazole-3-carboxylate intermediate and its synthesis method Active CN107759574B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710753540.0A CN107759574B (en) 2017-08-29 2017-08-29 A kind of 5-fluoro-1H-pyrazole-3-carboxylate intermediate and its synthesis method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710753540.0A CN107759574B (en) 2017-08-29 2017-08-29 A kind of 5-fluoro-1H-pyrazole-3-carboxylate intermediate and its synthesis method

Publications (2)

Publication Number Publication Date
CN107759574A CN107759574A (en) 2018-03-06
CN107759574B true CN107759574B (en) 2020-07-03

Family

ID=61265277

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710753540.0A Active CN107759574B (en) 2017-08-29 2017-08-29 A kind of 5-fluoro-1H-pyrazole-3-carboxylate intermediate and its synthesis method

Country Status (1)

Country Link
CN (1) CN107759574B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103068813A (en) * 2010-06-15 2013-04-24 拜耳知识产权有限责任公司 Anthranilic acid diamide derivatives
WO2017007756A1 (en) * 2015-07-06 2017-01-12 Rodin Therapeutics, Inc Hetero-halo inhibitors of histone deacetylase
WO2017136727A2 (en) * 2016-02-05 2017-08-10 Denali Therapeutics Inc. Compounds, compositions and methods

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103068813A (en) * 2010-06-15 2013-04-24 拜耳知识产权有限责任公司 Anthranilic acid diamide derivatives
WO2017007756A1 (en) * 2015-07-06 2017-01-12 Rodin Therapeutics, Inc Hetero-halo inhibitors of histone deacetylase
WO2017136727A2 (en) * 2016-02-05 2017-08-10 Denali Therapeutics Inc. Compounds, compositions and methods

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
"Reported, but Still Unknown."A Closer Look into 3,4-Bis- and 3,4,5-Tris(trifluoromethyl)pyrazoles;Igor I. Gerus,等;《J. Org. Chem.》;20111215;第77卷;第47-56页 *

Also Published As

Publication number Publication date
CN107759574A (en) 2018-03-06

Similar Documents

Publication Publication Date Title
Li et al. Synthesis and characterization of 5-substituted 8-hydroxyquinoline derivatives and their metal complexes
CN107176955A (en) A kind of Ba Rui replaces the preparation method of Buddhist nun
CN110066279A (en) Perfluoroalkyl substituted indole and isoquinoline compound and preparation method thereof
CN102548958A (en) Method for preparing tricyclic derivatives
DE602006000226T2 (en) Process for the preparation of Adapalene
WO2024212430A1 (en) Preparation method and use of novel taxane compound
CN112538091B (en) Synthesis method of bis- (p-carboxyphenylamino) phenylphosphine oxide flame retardant
CN114315563B (en) Process for producing branched carboxylic acid compound
CN105481694A (en) Synthetic method of 4-methoxyethyl acetoacetate
CN107759574B (en) A kind of 5-fluoro-1H-pyrazole-3-carboxylate intermediate and its synthesis method
CN101402573B (en) Bihydroxyl-2-acyl benzene acetic acid ester, producing method and uses thereof
TWI540119B (en) Compound, method for producing the same, and method for producing oseltamivir phosphate
TWI729662B (en) Sulfonamide compound and process for preparing sulfonamide compound
CN118598812A (en) Synthesis method of key intermediate of huperzine A
CN109776407B (en) Preparation method of 2-methyl-4-hydroxymethyl quinoline and derivatives thereof
CN106278928B (en) A kind of synthetic method of Oseltamivir phosphate isomer impurities
CN112028874B (en) Synthesis method of eritinib
CN105037428B (en) A kind of preparation method of coumarin-3-phosphonate derivative
CN116685567A (en) Hydroxy thienoimidazole derivative, vinyl thioether derivative, n-butylidene thioether derivative, and process for producing saturated straight-chain hydrocarbon-substituted thienoimidazole derivative
WO2022135300A1 (en) Synthesis and use of 1-benzyl-4-methyl-5-alkoxy-1,2,3,6-tetrahydropyridine derivative
CN109988070B (en) Intermediate of trans-1-hydroxy-1-(trifluoromethyl)-3-aminocyclobutane hydrochloride and preparation method and application
JP2502198B2 (en) Method for producing tri-lower alkanoyloxyboron
CN110668940A (en) Synthesis of α,β-Unsaturated Carboxylate Derivatives Catalyzed by Visible Light
CN113816855B (en) Method for synthesizing chiral allyl carboxylate
CN114057684B (en) Synthesis method of tiotropium bromide intermediate methyl bis (2-dithienyl) glycolate

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant